249 related articles for article (PubMed ID: 28760939)
21. Blood Pressure Measurement in SPRINT (Systolic Blood Pressure Intervention Trial).
Johnson KC; Whelton PK; Cushman WC; Cutler JA; Evans GW; Snyder JK; Ambrosius WT; Beddhu S; Cheung AK; Fine LJ; Lewis CE; Rahman M; Reboussin DM; Rocco MV; Oparil S; Wright JT;
Hypertension; 2018 May; 71(5):848-857. PubMed ID: 29531173
[TBL] [Abstract][Full Text] [Related]
22. Association of 1-Year Blood Pressure Variability With Long-term Mortality Among Adults With Coronary Artery Disease: A Post Hoc Analysis of a Randomized Clinical Trial.
Dasa O; Smith SM; Howard G; Cooper-DeHoff RM; Gong Y; Handberg E; Pepine CJ
JAMA Netw Open; 2021 Apr; 4(4):e218418. PubMed ID: 33914047
[TBL] [Abstract][Full Text] [Related]
23. Effects of Intensive Systolic Blood Pressure Lowering on Cardiovascular Events and Mortality in Patients With Type 2 Diabetes Mellitus on Standard Glycemic Control and in Those Without Diabetes Mellitus: Reconciling Results From ACCORD BP and SPRINT.
Beddhu S; Chertow GM; Greene T; Whelton PK; Ambrosius WT; Cheung AK; Cutler J; Fine L; Boucher R; Wei G; Zhang C; Kramer H; Bress AP; Kimmel PL; Oparil S; Lewis CE; Rahman M; Cushman WC
J Am Heart Assoc; 2018 Sep; 7(18):e009326. PubMed ID: 30371182
[TBL] [Abstract][Full Text] [Related]
24. Clinical Outcomes by Race and Ethnicity in the Systolic Blood Pressure Intervention Trial (SPRINT): A Randomized Clinical Trial.
Still CH; Rodriguez CJ; Wright JT; Craven TE; Bress AP; Chertow GM; Whelton PK; Whittle JC; Freedman BI; Johnson KC; Foy CG; He J; Kostis JB; Lash JP; Pedley CF; Pisoni R; Powell JR; Wall BM;
Am J Hypertens; 2017 Dec; 31(1):97-107. PubMed ID: 28985268
[TBL] [Abstract][Full Text] [Related]
25. Visit-to-visit variability of blood pressure and death, end-stage renal disease, and cardiovascular events in patients with chronic kidney disease.
Chang TI; Tabada GH; Yang J; Tan TC; Go AS
J Hypertens; 2016 Feb; 34(2):244-52. PubMed ID: 26599220
[TBL] [Abstract][Full Text] [Related]
26. Association of Intensive Blood Pressure Control and Living Arrangement on Cardiovascular Outcomes by Race: Post Hoc Analysis of SPRINT Randomized Clinical Trial.
Inoue K; Watson KE; Kondo N; Horwich T; Hsu W; Bui AAT; Duru OK
JAMA Netw Open; 2022 Mar; 5(3):e222037. PubMed ID: 35285922
[TBL] [Abstract][Full Text] [Related]
27. Association of Blood Pressure Variability and Diuretics With Cardiovascular Events in Patients With Chronic Kidney Disease Stages 1-5.
Gregg LP; Hedayati SS; Yang H; Van Buren PN; Banerjee S; Navaneethan SD; Virani SS; Winkelmayer WC; Alvarez CA
Hypertension; 2021 Mar; 77(3):948-959. PubMed ID: 33423525
[TBL] [Abstract][Full Text] [Related]
28. Intensive vs Standard Blood Pressure Control and Cardiovascular Disease Outcomes in Adults Aged ≥75 Years: A Randomized Clinical Trial.
Williamson JD; Supiano MA; Applegate WB; Berlowitz DR; Campbell RC; Chertow GM; Fine LJ; Haley WE; Hawfield AT; Ix JH; Kitzman DW; Kostis JB; Krousel-Wood MA; Launer LJ; Oparil S; Rodriguez CJ; Roumie CL; Shorr RI; Sink KM; Wadley VG; Whelton PK; Whittle J; Woolard NF; Wright JT; Pajewski NM;
JAMA; 2016 Jun; 315(24):2673-82. PubMed ID: 27195814
[TBL] [Abstract][Full Text] [Related]
29. Personalizing the Intensity of Blood Pressure Control: Modeling the Heterogeneity of Risks and Benefits From SPRINT (Systolic Blood Pressure Intervention Trial).
Patel KK; Arnold SV; Chan PS; Tang Y; Pokharel Y; Jones PG; Spertus JA
Circ Cardiovasc Qual Outcomes; 2017 Apr; 10(4):. PubMed ID: 28373269
[TBL] [Abstract][Full Text] [Related]
30. Increased visit-to-visit blood pressure variability is associated with worse cardiovascular outcomes in low ejection fraction heart failure patients: Insights from the HEAAL study.
Rossignol P; Girerd N; Gregory D; Massaro J; Konstam MA; Zannad F
Int J Cardiol; 2015; 187():183-9. PubMed ID: 25828348
[TBL] [Abstract][Full Text] [Related]
31. Visit-to-visit blood pressure variability is a strong predictor of cardiovascular events in hemodialysis: insights from FOSIDIAL.
Rossignol P; Cridlig J; Lehert P; Kessler M; Zannad F
Hypertension; 2012 Aug; 60(2):339-46. PubMed ID: 22777936
[TBL] [Abstract][Full Text] [Related]
32. Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic Hypertension in Europe Trial Investigators.
Staessen JA; Thijs L; Fagard R; O'Brien ET; Clement D; de Leeuw PW; Mancia G; Nachev C; Palatini P; Parati G; Tuomilehto J; Webster J
JAMA; 1999 Aug; 282(6):539-46. PubMed ID: 10450715
[TBL] [Abstract][Full Text] [Related]
33. Antihypertensive Medication Regimens Used in the Systolic Blood Pressure Intervention Trial.
Derington CG; Bress AP; Moran AE; Weintraub WS; Herrick JS; Cushman WC; Kronish IM; Stults B; Shimbo D; Muntner P; Greene T; Bates JT; Chang TI; Katz LA; Rehman SU; Roumie CL; Tamariz L; King JB
Hypertension; 2023 Mar; 80(3):590-597. PubMed ID: 36519451
[TBL] [Abstract][Full Text] [Related]
34. Benefit and harm of intensive blood pressure treatment: Derivation and validation of risk models using data from the SPRINT and ACCORD trials.
Basu S; Sussman JB; Rigdon J; Steimle L; Denton BT; Hayward RA
PLoS Med; 2017 Oct; 14(10):e1002410. PubMed ID: 29040268
[TBL] [Abstract][Full Text] [Related]
35. Effect of Baseline Kidney Function on the Risk of Recurrent Stroke and on Effects of Intensive Blood Pressure Control in Patients With Previous Lacunar Stroke: A Post Hoc Analysis of the SPS3 Trial (Secondary Prevention of Small Subcortical Strokes).
Agarwal A; Cheung AK; Ma J; Cho M; Li M
J Am Heart Assoc; 2019 Aug; 8(16):e013098. PubMed ID: 31423869
[TBL] [Abstract][Full Text] [Related]
36. Orthostatic Hypotension in the ACCORD (Action to Control Cardiovascular Risk in Diabetes) Blood Pressure Trial: Prevalence, Incidence, and Prognostic Significance.
Fleg JL; Evans GW; Margolis KL; Barzilay J; Basile JN; Bigger JT; Cutler JA; Grimm R; Pedley C; Peterson K; Pop-Busui R; Sperl-Hillen J; Cushman WC
Hypertension; 2016 Oct; 68(4):888-95. PubMed ID: 27504006
[TBL] [Abstract][Full Text] [Related]
37. Intensive Blood Pressure Treatment Reduced Stroke Risk in Patients With Albuminuria in the SPRINT Trial.
Leitão L; Soares-Dos-Reis R; Neves JS; Baptista RB; Bigotte Vieira M; Mc Causland FR
Stroke; 2019 Dec; 50(12):3639-3642. PubMed ID: 31637971
[TBL] [Abstract][Full Text] [Related]
38. Effect of Intensive Versus Standard Clinic-Based Hypertension Management on Ambulatory Blood Pressure: Results From the SPRINT (Systolic Blood Pressure Intervention Trial) Ambulatory Blood Pressure Study.
Drawz PE; Pajewski NM; Bates JT; Bello NA; Cushman WC; Dwyer JP; Fine LJ; Goff DC; Haley WE; Krousel-Wood M; McWilliams A; Rifkin DE; Slinin Y; Taylor A; Townsend R; Wall B; Wright JT; Rahman M
Hypertension; 2017 Jan; 69(1):42-50. PubMed ID: 27849563
[TBL] [Abstract][Full Text] [Related]
39. On-Treatment Blood Pressure and Cardiovascular Outcomes in Older Adults With Isolated Systolic Hypertension.
Yano Y; Rakugi H; Bakris GL; Lloyd-Jones DM; Oparil S; Saruta T; Shimada K; Matsuoka H; Imai Y; Ogihara T
Hypertension; 2017 Feb; 69(2):220-227. PubMed ID: 28049699
[TBL] [Abstract][Full Text] [Related]
40. Visit-to-visit variability in blood pressure and kidney and cardiovascular outcomes in patients with type 2 diabetes and nephropathy: a post hoc analysis from the RENAAL study and the Irbesartan Diabetic Nephropathy Trial.
McMullan CJ; Lambers Heerspink HJ; Parving HH; Dwyer JP; Forman JP; de Zeeuw D
Am J Kidney Dis; 2014 Nov; 64(5):714-22. PubMed ID: 25064674
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
